Ethinyl Estradiol: all 115 studies that test it
Page 2 of 2. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.
- Evaluation of Women's Experience With EVRA (Norelgestromin + Ethinyl Estradiol) Transdermal Contraceptive Patch Compared With Previous Methods of Contraception.CompletedNCT00261482Phase 4
- The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy FemalesCompletedNCT00254800Phase 1
- Study Evaluating Effects of Levonorgestrel and Ethinyl Estradiol on OvulationCompletedNCT00254189Phase 2
- A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Mercilon.CompletedNCT00236782Phase 3
- A Study of Efficacy and Safety With the Transdermal Contraceptive System.CompletedNCT00236769Phase 3
- Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat DysmenorrheaCompletedNCT00212342Phase 3
- Efficacy and Safety,Long-term Study of Low-dose Oral Contraceptive Pill to Treat Dysmenorrhea.CompletedNCT00212277Phase 3
- Efficacy and Safety Study in Postmenopausal Women to Determine the Lowest Effective Dose for Relief of Moderate to Severe Hot-FlushesCompletedNCT00206622Phase 4
- Administration of Oral Contraceptives at Different Times of the Follicular Phase of the Menstrual CycleCompletedNCT00204438Not applicable
- Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric DisorderCompletedNCT00195559Phase 3
- Estrogen Priming to Increase the Efficacy of Adjuvant Chemotherapy in Operable Breast CancerTerminatedNCT00193726Phase 3
- Treatment of Hot Flushes in Asian Women With Ultra-low Dose Estradiol PatchCompletedNCT00185237Phase 3
- Study Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMSCompletedNCT00161681Phase 3
- Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric DisorderCompletedNCT00128934Phase 3
- Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon CancerCompletedNCT00033358Phase 2